IMPAX LABORATORIES INC Business Operations Contracts & Agreements
7 Contracts & Agreements
- Administration Agreements (3 contracts)
- Development Agreements (1)
- MOUs (1)
- Services Agreements (1)
- Supply Agreements (1)
- Master Supply Agreement, dated as of December 19, 2017, between the Company, Bora Pharmaceuticals Co., Ltd. and Impax Laboratories (Taiwan), Inc (Filed With SEC on March 1, 2018)
- Memorandum of Understanding dated as of December 16, 2017 by and among Amneal Pharmaceuticals LLC, Paul M. Bisaro, Impax Laboratories, Inc. and Atlas Holdings, Inc (Filed With SEC on December 20, 2017)
- FIRST AMENDMENT TO JOINT DEVELOPMENT AGREEMENT DATED NOVEMBER 26, 2008 (Filed With SEC on February 28, 2012)
- 62 ANDAs approved by the Food and Drug Administration (FDA), which include generic versions of brand name pharmaceuticals such as Brethine, Florinef, Minocin, Claritin-D 12-hour,... (Filed With SEC on February 25, 2011)
- 62 ANDAs approved by the Food and Drug Administration (FDA), which include generic versions of brand name pharmaceuticals such as Brethine, Florinef, Minocin, Claritin-D 12-hour,... (Filed With SEC on February 25, 2011)
- 62 ANDAs approved by the Food and Drug Administration (FDA), which include generic versions of brand name pharmaceuticals such as Brethine, Florinef, Minocin, Claritin-D 12-hour,... (Filed With SEC on February 25, 2011)
- PROMOTIONAL SERVICES AGREEMENT (Filed With SEC on July 2, 2009)
